DKSH has signed an agreement to acquire Biomedic, a leading Vietnamese distributor in biotechnology and diagnostics, to strengthen its position in the region's growing healthcare sector.

Target Company Overview

DKSH has announced its agreement to acquire Biomedic Science Material Joint Stock Company, referred to as Biomedic. Established in 2008 and headquartered in Hanoi, Vietnam, Biomedic is a prominent distributor of equipment and reagents used in the biotechnology and diagnostic sectors. The company employs over 80 professionals across three locations in Vietnam and generates annual net sales of approximately CHF 12 million, demonstrating solid profitability. Biomedic serves a diverse clientele within the Vietnamese healthcare industry, which includes prestigious hospitals, testing centers, and fertility support centers.

Biomedic has cultivated long-standing relationships with various renowned blue-chip clients, enhancing its reputation within the market. The company primarily operates on an equipment placement model, securing a consistent revenue stream through recurring consumable sales. Mr. Cao Tien Dung, the founder of Biomedic, expressed optimism regarding the acquisition, noting that it represents a significant step in the firm’s growth trajectory. He emphasized the potential for Biomedic to scale its operations, benefiting from DKSH’s extensive sales channels.

Industry Overview in Vietnam

The biotechnology and diagnostic industry in Vietnam is experiencing substantial growth, driven by increased demand for advanced healthcare solutions. The sector encompasses a range of applications, including oncology, infectious diseases, an